Reduced RBC, HGB, and HCT levels in Cu300-treated mice are indicative of hypochromic microcytic anemia, consistent with previous findings that excess copper impairs erythropoiesis, disrupts iron metabolism, and induces oxidative stress in hematopoietic tissues [23,24]. The gene discussed is CYGB; the disease is microcytic anemia.